Journal of VitreoRetinal Diseases最新文献

Long-Term Cost Analysis of Initial Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Performed in the Operating Room vs the Clinic. 术前全视网膜光凝治疗增殖性糖尿病视网膜病变的长期成本分析。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-06-13 DOI: 10.1177/24741264251346822

Sean C Drummond, Brenton T Bicknell, Jack E Feist, Jason N Crosson, Richard M Feist

{"title":"Long-Term Cost Analysis of Initial Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Performed in the Operating Room vs the Clinic.","authors":"Sean C Drummond, Brenton T Bicknell, Jack E Feist, Jason N Crosson, Richard M Feist","doi":"10.1177/24741264251346822","DOIUrl":"10.1177/24741264251346822","url":null,"abstract":"Purpose: To evaluate a treatment-naïve cohort of patients with proliferative diabetic retinopathy (PDR) and assess the costs of panretinal photocoagulation (PRP) initially performed in the operating room or the clinic, incorporating the cost of the additional follow-up procedures required for each treatment group. Methods: A retrospective review was performed of patients with PDR initially treated with PRP in the operating room or the clinic. Cost data were derived from Current Procedural Terminology codes, and estimated mean facility costs were provided. For each cohort, negative binomial regressions were used to compare counts of subsequent interventions, and visual acuity (VA) outcomes and dollars per patient-treatment year were compared with paired t tests. Results: Eighty-two eyes of 53 patients met the inclusion criteria. The operating room cohort included 56 eyes of 38 patients, while the clinic cohort included 26 eyes of 16 patients. Patients had a minimum follow-up of more than 3 years. The operating room cohort required fewer subsequent PRP treatments (mean, 1.0 vs 2.1; P < .05) and surgeries (mean, 0.3 vs 0.7; P < .05) than the clinic cohort. The mean best-corrected VA (BCVA) after treatment was significantly better in the operating room cohort (0.30 ± 0.40 logMAR; Snellen equivalent, 20/39.9) than the clinic cohort (0.75 ± 0.81 logMAR; Snellen equivalent, 20/112.5) (P < .05). The cost per patient-treatment year was similar between the cohorts (operating room, $5,886.79; clinic, $5,657.50) (P = .75). Conclusions: PRP initially administered in the operating room was equal in cost to clinic administration and required fewer subsequent PRP sessions and surgical treatments. In addition, there was a significant improvement in the final BCVA.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251346822"},"PeriodicalIF":0.5,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144302419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Performance and Outcomes of a 20 000 Cuts-per-Minute, 25-Gauge, Beveled-Tip Vitrectomy Probe. 25号斜尖玻璃体切割探头每分钟切割次数20000刀的临床表现和效果。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-06-12 DOI: 10.1177/24741264251338871

Harvey S Uy, Jose Carlo M Artiaga, Katrina Beatriz M Lim, Pik Sha Chan, Jordan T Famadico

{"title":"Clinical Performance and Outcomes of a 20 000 Cuts-per-Minute, 25-Gauge, Beveled-Tip Vitrectomy Probe.","authors":"Harvey S Uy, Jose Carlo M Artiaga, Katrina Beatriz M Lim, Pik Sha Chan, Jordan T Famadico","doi":"10.1177/24741264251338871","DOIUrl":"10.1177/24741264251338871","url":null,"abstract":"Purpose: To report the clinical outcomes and instrument performance of a 25-gauge, 20 000 cuts-per-minute (cpm), beveled-tip vitrectomy probe system. Methods: This prospective consecutive case series comprised eyes having primary pars plana vitrectomy (PPV) using a 20 000 cpm vitrectomy probe system (20 000 cpm group). The main outcome measures were the rate of success, operative times, number of steps, 3-month distance-corrected visual acuity (DCVA), ancillary instruments use, and adverse events (AEs). A comparative analysis with the results of a previously published series of eyes that had PPV with a 10 000 cpm, beveled-tip vitrectomy system (10 000 cpm group) was performed. Results: The study included 55 eyes. The surgical objectives were attained in all eyes. The mean logMAR DCVA improved from 0.96 preoperatively to 0.35 postoperatively (at 3 months) (P < .0001). The mean (±SD) total operative time, core vitrectomy time, shave vitrectomy time, and total vitrectomy time was 1964.27 ± 846.92 seconds, 174.87 ± 116.23 seconds, 478.41 ± 387.30 seconds, and 655.60 ± 397.53 seconds, respectively. The mean number of surgical steps was 4.05 ± 1.06 and of ancillary instrument exchanges, 3.23 ± 1.89. The mean postoperative day 1 pain score was 0.16 ± 0.46. Two eyes had elevated intraocular pressure postoperatively and 1 eye had hypotony. There were fewer ancillary instrument exchanges (P < .001) and fewer AEs (P = .044) in the 20 000 cpm group than in the 10 000 cpm group. Conclusions: Both the 20 000 and 10 000 systems are effective and safe for the treatment of various vitreoretinal indications. The potential advantages of the 20 000 system include reduced use of ancillary instrumentation and lower AE rates.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251338871"},"PeriodicalIF":0.5,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144302418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Serous Choroidal Detachment and Retinopathy With Ipsilateral Carotid Cavernous Fistula. 浆液性脉络膜脱离和视网膜病变伴同侧颈动脉海绵状瘘。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-06-02 DOI: 10.1177/24741264251340437

Amira Abbas, Jared Ebert, Jordana Fein

引用次数: 0

Delayed-Onset Endophthalmitis After Intravitreal Dexamethasone Implantation. 玻璃体内地塞米松植入后的迟发性眼内炎。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-31 DOI: 10.1177/24741264251346825

April Enger, James Dossett, Christine Clavell, Alen Eid, William Kuenstner, Nicole Pumariega, Ghassan Ghorayeb

{"title":"Delayed-Onset Endophthalmitis After Intravitreal Dexamethasone Implantation.","authors":"April Enger, James Dossett, Christine Clavell, Alen Eid, William Kuenstner, Nicole Pumariega, Ghassan Ghorayeb","doi":"10.1177/24741264251346825","DOIUrl":"10.1177/24741264251346825","url":null,"abstract":"Purpose: To present a series of cases of acute endophthalmitis after intravitreal (IVT) sustained-release dexamethasone implantation (Ozurdex) with an unusually delayed onset. Methods: A retrospective review was performed of 3 patients presenting to West Virginia University Eye Institute and diagnosed with acute endophthalmitis 16 days, 18 days, and 35 days after dexamethasone implantation. The presenting visual acuities (VAs) were counting fingers at face to hand motions (HM) only. Each patient had an aqueous or vitreous tap with injection of IVT antibiotics followed by pars plana vitrectomy. The dexamethasone implants were not removed. Results: All cultures returned positive, including Staphylococcus aureus, Staphylococcus epidermidis, and Granulicatella adiacens. The 3 patients' final VAs were 20/60, 20/100, and HM only, respectively. Conclusions: Delayed-onset acute endophthalmitis after dexamethasone implantation represents a clinical challenge, potentially occurring up to weeks after the injection. Sustained suspicion for endophthalmitis is warranted given that cases may present beyond what is typical for postinjection endophthalmitis.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251346825"},"PeriodicalIF":0.5,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144208901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Characteristics, Outcomes, and Complications Associated With Delayed Diagnosis of Intraocular Foreign Body. 眼内异物延迟诊断的临床特征、结果和并发症。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-29 DOI: 10.1177/24741264251339090

Melissa Yuan, Lindsay K Kozek, Sandra Hoyek, Jose Davila, Leo Kim, Filippos Vingopoulos, Dan Gong, Lucy Young, Frances Wu, Grayson Armstrong, Dean Eliott, Mark P Breazzano, Rajeev Seth, Jonathan F Russell, Jesse Sengillo, Benjamin Lin, Benjamin Fowler, Lucia Sobrin, John B Miller, Nimesh A Patel

{"title":"Clinical Characteristics, Outcomes, and Complications Associated With Delayed Diagnosis of Intraocular Foreign Body.","authors":"Melissa Yuan, Lindsay K Kozek, Sandra Hoyek, Jose Davila, Leo Kim, Filippos Vingopoulos, Dan Gong, Lucy Young, Frances Wu, Grayson Armstrong, Dean Eliott, Mark P Breazzano, Rajeev Seth, Jonathan F Russell, Jesse Sengillo, Benjamin Lin, Benjamin Fowler, Lucia Sobrin, John B Miller, Nimesh A Patel","doi":"10.1177/24741264251339090","DOIUrl":"10.1177/24741264251339090","url":null,"abstract":"Purpose: To describe the clinical characteristics, outcomes, and complications in cases of intraocular foreign bodies (IOFBs) when the diagnosis is missed or delayed. Methods: This nonconsecutive case series was a retrospective multicenter study of adult patients with a delayed diagnosis of IOFB, defined as initially presenting elsewhere with a missed diagnosis or a delay of more than 24 hours to seek care. Results: Eighteen eyes were included. The mean (±SD) presenting logMAR visual acuity (VA) was 0.45 ± 0.70 (Snellen equivalent, 20/56). The most common presenting symptom was decreased vision (11 patients [61%]). The general emergency department setting accounted for most initial evaluations (11 patients [61%]); however, 6 patients (33%) were seen in an outpatient setting by an optometrist, ophthalmologist, or both. The most common anatomic locations of the IOFBs were in the iris/anterior chamber (4 [22%]) or lens (4 [22%]) followed by the pars plana/ciliary body (3 [17%]), vitreous (3 [17%]), or retina (3 [17%]). Complications at presentation included endophthalmitis (1 [6%]), retinal detachment (1 [6%]), and retinal tears (4 [22%]). Five patients (28%) had siderosis at presentation. The mean final logMAR VA was 0.13 ± 0.32 (Snellen equivalent, 20/26). At the last follow-up, 15 eyes (83%) had a VA of 20/30 or better. The median follow-up was 139 days (IQR, 86-557). Conclusions: Eyes with a delayed diagnosis of IOFBs often present with good vision and self-sealing wounds. Missed IOFBs can be associated with siderosis, RD, and endophthalmitis. Visual outcomes may be salvaged with prompt treatment.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251339090"},"PeriodicalIF":0.5,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12122470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Patient Satisfaction in Ophthalmology: The Impact of Remote Scribes. 眼科患者满意度：远程抄写员的影响。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-28 DOI: 10.1177/24741264251340104

Ryung Lee, Jeanette Du, Eric L Wan, Geena Kim, Mohsin H Ali, Michael M Lai

{"title":"Patient Satisfaction in Ophthalmology: The Impact of Remote Scribes.","authors":"Ryung Lee, Jeanette Du, Eric L Wan, Geena Kim, Mohsin H Ali, Michael M Lai","doi":"10.1177/24741264251340104","DOIUrl":"10.1177/24741264251340104","url":null,"abstract":"Purpose: To determine whether remote scribing is associated with patient satisfaction. Methods: Physicians were included based on predetermined criteria. For all physicians, Net Promoter Score response data were collected for 3 consecutive months immediately before and 6 months after the transition to remote scribes. Over 2 years, 272 885 responses were analyzed. Patient time spent in the office was also assessed. Results: Twenty-three physicians transitioned to remote scribes between March 2022 and September 2023. For participating physicians, the mean Net Promoter Score rating improved from 9.34 to 9.44 (P = .008) for \"likelihood of recommending physician\" and from 9.54 to 9.60 (P < .001) for \"likelihood of recommending practice.\" After the transition, the mean time spent in the \"primary waiting room\" decreased from 14.88 minutes to 13.41 minutes (P < .001) and the mean time spent in the \"exam room\" decreased from 22.89 minutes to 21.22 minutes (P < .001). All secondary outcomes improved after the transition. Conclusions: After implementing remote scribes and based on Net Promoter Score ratings, patient satisfaction scores improved and patient wait time decreased. Physicians may consider using remote scribes to enhance patient satisfaction and clinical flow.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251340104"},"PeriodicalIF":0.5,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12119522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Epiretinal Membranes Associated With Choroidal Melanoma. 与脉络膜黑色素瘤相关的视网膜上膜。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-22 DOI: 10.1177/24741264251336334

Feng Li, David M Hinkle, Paul T Finger

{"title":"Epiretinal Membranes Associated With Choroidal Melanoma.","authors":"Feng Li, David M Hinkle, Paul T Finger","doi":"10.1177/24741264251336334","DOIUrl":"10.1177/24741264251336334","url":null,"abstract":"Purpose: To describe the prevalence of epiretinal membrane (ERM) in eyes with choroidal melanoma. Methods: A retrospective clinical case review was conducted to evaluate the prevalence of ERMs. Examinations included ophthalmoscopy, fundus photography, and optical coherence tomography. Multivariate analysis evaluated ERMs with choroidal melanoma, retinal detachment (RD) before treatment, plaque radiation dose to the fovea, radiation retinopathy, and intravitreal (IVT) antivascular endothelial growth factor (anti-VEGF) treatment. Contralateral eyes were used as controls. Results: The study included 373 patients (746 eyes). ERMs were found in 34% of eyes with choroidal melanoma that were treated and 12.1% of control eyes. A larger tumor size (increasing American Joint Committee on Cancer cT category) was significantly associated with the presence of an ERM at baseline. In addition, a higher radiation dose to the fovea was associated with ERM development. Risk factors determined by multivariate analysis included radiation retinopathy (odds ratio [OR], 3.00), anti-VEGF injections (OR, 2.87), and RD at presentation (OR, 3.19). Conclusions: This study found a significantly higher prevalence of ERMs in eyes with choroidal melanoma. Risk factors contributing to ERM development included the radiation dose, radiation retinopathy, IVT anti-VEGF injections, and RD. Of these factors, the presence of RD at the initial diagnosis was the strongest predictor of the occurrence of a secondary ERM.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251336334"},"PeriodicalIF":0.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12098326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Timing of Epiretinal Membrane Surgery After Uncomplicated Retinal Detachment Repair. 无并发症视网膜脱离修复后视网膜外膜手术时机选择。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-15 DOI: 10.1177/24741264251337107

Prithvi R Bomdica, E Anne Shepherd, Rishabh Gupta, Vivek Chaturvedi

{"title":"Timing of Epiretinal Membrane Surgery After Uncomplicated Retinal Detachment Repair.","authors":"Prithvi R Bomdica, E Anne Shepherd, Rishabh Gupta, Vivek Chaturvedi","doi":"10.1177/24741264251337107","DOIUrl":"10.1177/24741264251337107","url":null,"abstract":"Purpose: To evaluate the features and outcomes of postoperative epiretinal membranes (ERMs) after retinal detachment (RD) repair based on the timing of macular peeling (MP). Methods: This retrospective consecutive case series comprised patients who had rhegmatogenous RD repair, developed an ERM, and had MP within 1 year. Results: Of the ERMs, 91% (50/55) were diagnosed between 1 month and 3 months after RD repair. When MP was performed less than 6 months after RD repair (n = 37), the final logMAR visual acuity (VA) was 0.31; this was statistically better than when MP was performed 6 months after RD repair or later (0.63, n = 18) (P = .005). In the 6-months or later MP cohort, 61% (11/18) had cataract surgery between the RD repair and MP while 7 patients were pseudophakic at RD presentation. Of the ERMs, 65%, 24%, and 11% were stage 4, stage 3, and stage 2, respectively; the final logMAR VA was 0.43, 0.38, and 0.30, respectively. There was no significant difference in the final VA or macular status between the stages. Overall, the mean logMAR VA before MP was 0.87, which improved to a final VA of 0.41 after MP (P < .001). Conclusions: ERMs formed after RD repair were most likely to be stage 4; however, this did not affect the final VA. The final VA was significantly better when MP was performed less than 6 months after RD repair. This is relevant because retina surgeons may be delaying MP until after cataract surgery.","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264251337107"},"PeriodicalIF":0.5,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Resolution of Myopic Macular Retinoschisis and Macular Hole With Topical Medical Therapy. 局部药物治疗解决近视黄斑视网膜裂和黄斑孔。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-15 DOI: 10.1177/24741264251340107

Gregg T Kokame, Shay Nakahira, Kael Yamane, Jasmine Chen, Emi Luo, Elysse S Tom

引用次数: 0

Embodying Resilience in Retina Specialty Care. 在视网膜专科护理中体现弹性。

IF 0.5

Journal of VitreoRetinal Diseases Pub Date : 2025-05-15 eCollection Date: 2025-05-01 DOI: 10.1177/24741264251337795

Timothy G Murray

引用次数: 0